Biocon Balance Sheet Health
Financial Health criteria checks 2/6
Biocon has a total shareholder equity of ₹267.2B and total debt of ₹161.5B, which brings its debt-to-equity ratio to 60.4%. Its total assets and total liabilities are ₹571.3B and ₹304.1B respectively. Biocon's EBIT is ₹15.9B making its interest coverage ratio 2. It has cash and short-term investments of ₹26.5B.
Key information
60.4%
Debt to equity ratio
₹161.50b
Debt
| Interest coverage ratio | 2x |
| Cash | ₹26.50b |
| Equity | ₹267.20b |
| Total liabilities | ₹304.08b |
| Total assets | ₹571.28b |
Recent financial health updates
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20
Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Recent updates
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E
Nov 01Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?
Oct 14These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors
Jun 29Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations
May 24Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26Financial Position Analysis
Short Term Liabilities: BIOCON's short term assets (₹151.5B) do not cover its short term liabilities (₹158.1B).
Long Term Liabilities: BIOCON's short term assets (₹151.5B) exceed its long term liabilities (₹146.0B).
Debt to Equity History and Analysis
Debt Level: BIOCON's net debt to equity ratio (50.5%) is considered high.
Reducing Debt: BIOCON's debt to equity ratio has increased from 30.5% to 60.4% over the past 5 years.
Debt Coverage: BIOCON's debt is well covered by operating cash flow (25%).
Interest Coverage: BIOCON's interest payments on its debt are not well covered by EBIT (2x coverage).